SHEILA DENEUS: Open Payments
NPI 1982486239 · EAST PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,315 in 45 payments from 9 companies in 2025. Trend: 2023 $22 · 2024 $140 · 2025 $1,315
Food & beverage: $1,315
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $441 |
| Novo Nordisk Inc | 3 | $232 |
| Otsuka America Pharmaceutical, Inc. | 10 | $198 |
| ABBVIE INC. | 11 | $149 |
| Lundbeck LLC | 5 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Astellas Pharma US Inc | 1 | $29 |
| Insulet Corporation | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $23 |
Products named: REXULTI, BREZTRI, Wegovy, FARXIGA, Ozempic, QULIPTA, CAPLYTA, AIRSUPRA.
Industry payments across RI — which companies pay providers there.
